Biomea Fusion, Inc. (BMEA) — Insider Trading

AI-Powered SEC Filing Analysis

Latest Insider Trading Filed: 2026-04-03

Key Insights

Insider Michael J.M. Hitchcock, Interim CEO of Biomea Fusion, acquired 667,477 stock options with an exercise price of $1.49, representing a substantial equity grant that aligns his interests with the company's success.
The options vest over 4 years in 16 equal quarterly installments, indicating a long-term commitment from the Interim CEO to drive the company's growth and development.
This equity award signals that the Interim CEO believes in the company's future prospects and is willing to take a significant equity stake, which could be viewed positively by investors.

Want the newest filings?

This analysis covers the filing from 2026-04-03. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Insider Trading filings

Filed: 2026-04-03

Rainer M. Erdtmann, the President, Chief Operating Officer, Principal Financial Officer, and Principal Accounting Officer of Biomea Fusion, Inc., has been granted a stock option to purchase 452,512 shares of the company's common stock, vesting over 4 years.
The exercise price of the stock option is $1.49 per share, which appears to be the fair market value at the time of grant on April 1, 2026.
This grant is a positive sign that the company is incentivizing its key executive to drive long-term growth and value creation for shareholders.

Other reports for Biomea Fusion, Inc.

Current Report Annual Report

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.